COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with?

In conclusion, during the COVID-19 pandemic, due to the key roles of cytokines in the promotion of the disease, the rheumatic patients may benefit from continuing their previous treatment, which may have protective effects.
PMID: 33213130 [PubMed - in process]

Source: Reumatismo - November 19, 2020 Category: Rheumatology Authors: Ahmadinejad Z, Assari R, Ayoobi Yazdi N, Mazloomi SH, Javanshayani P, Khalili Afousi H, Ziaee V Tags: Reumatismo Source Type: research